Delivery Order SPE2DB24D2011-SPE2DB25FBPVG

Award Date 1/21/25
Potential Completion Date 1/22/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,729.49, is for the delivery of 120 units of the drug TLANDO 112.5 MG CAPSULE. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 19, 2023. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a...
The U.S. government's Defense Logistics Agency (DLA) awarded a $7,357.18 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract, with a completion date of February 11, 2025, is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, has awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,785.29, has an ultimate completion date of January 6, 2025. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $111,908.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,081.60 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA that runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,390.73 firm-fixed-price delivery order contract has a completion date of February 21, 2025 and does not have a set-aside designation. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,830.92 firm-fixed-price delivery order contract has an ultimate completion date of January 22, 2025. The contract supports the DLA Troop Support Medical program, providing a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines,...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,820.16 contract has an ultimate completion date of January 22, 2025 and provides a range of pharmaceutical products and medical supplies to support military healthcare programs. This award is associated with Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,185.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award is between the U.S. Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,653.12 firm-fixed-price delivery order, awarded on November 2, 2022, is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB25FBPVG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,022.59 firm-fixed-price delivery order is for the supply of TLANDO 112.5 MG CAPSULE 120S to support federal healthcare programs. The contract has an ultimate completion date of January 22, 2025.

The award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/21/25, 9:47 AM